Article info
PDFReview
Future of biomarker evaluation in the realm of artificial intelligence algorithms: application in improved therapeutic stratification of patients with breast and prostate cancer
- Correspondence to Dr Jenny Fitzgerald, Deciphex Ltd, Dublin City University, Dublin, Ireland; Jenny.fitzgerald{at}deciphex.com
Citation
Future of biomarker evaluation in the realm of artificial intelligence algorithms: application in improved therapeutic stratification of patients with breast and prostate cancer
Publication history
- Received April 23, 2021
- Accepted April 25, 2021
- First published June 11, 2021.
Online issue publication
June 18, 2021
Article Versions
- Previous version (18 June 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.